NewAmsterdam Pharma Co N.V. ($NAMS)
Filing Information
| Accession Number | 0001193125-26-025012 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 27, 2026 |
| Document Date | Jan 23, 2026 |
| Document | View SEC Filing |
Transactions
8
Total Shares
217,716
Total Value
$3,206,877.91
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Accounting Officer | Ordinary Shares | โ | Jan 23, 2026 | Exercise/Conversion | 38,172 | $10.90 | $416,074.80 | 62,525 | Direct | โ | View Details | |
Chief Accounting Officer | Ordinary Shares | โ | Jan 23, 2026 | Sale | 25,405 | $33.44 | $849,543.20 | 37,120 | Direct | โ | View Details | |
Chief Accounting Officer | Ordinary Shares | โ | Jan 23, 2026 | Sale | 12,767 | $34.37 | $438,801.79 | 24,353 | Direct | โ | View Details | |
Chief Accounting Officer | Ordinary Shares | โ | Jan 26, 2026 | Exercise/Conversion | 34,400 | $10.90 | $374,960.00 | 58,753 | Direct | โ | View Details | |
Chief Accounting Officer | Ordinary Shares | โ | Jan 26, 2026 | Sale | 34,091 | $32.77 | $1,117,162.07 | 24,662 | Direct | โ | View Details | |
Chief Accounting Officer | Ordinary Shares | โ | Jan 26, 2026 | Sale | 309 | $33.45 | $10,336.05 | 24,353 | Direct | โ | View Details | |
Chief Accounting Officer | Option (right to buy) | Derivative | Jan 23, 2026 | Exercise/Conversion | 38,172 | $0.00 | $0.00 | 179,962 | Direct | โ | View Details | |
Chief Accounting Officer | Option (right to buy) | Derivative | Jan 26, 2026 | Exercise/Conversion | 34,400 | $0.00 | $0.00 | 145,562 | Direct | โ | View Details |